Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HUMAN PAPILLOMA VIRUS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00578227
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 814
Not applicableNot Yet RecruitingNCT07697196
What this trial is testing

Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration

Who this might be right for
HPV InfectionHPV IntegrationHPV Disease+3 more
IRCCS San Raffaele 42
Testing effectiveness (Phase 2)Ended earlyNCT02225496
What this trial is testing

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Cancer
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT05746988
What this trial is testing

Carrageenan for the Prevention of Oral HPV Infection

Who this might be right for
Human Papilloma Virus
McGill University 40
Not applicableStudy completedNCT04180462
What this trial is testing

Increasing Optimal Use of HPV Vaccination in Primary Care

Who this might be right for
Human Papillomavirus Vaccines
Washington University School of Medicine 20
Not applicableStudy completedNCT01101542
What this trial is testing

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 3,091
Not applicableLooking for participantsNCT06598475
What this trial is testing

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Who this might be right for
Human Papillomavirus Infection
The University of Texas Health Science Center, Houston 225
Post-approval studies (Phase 4)Active Not RecruitingNCT07314307
What this trial is testing

Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

Who this might be right for
Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection
Karolinska Institutet 150,000
Not applicableUnknownNCT00155792
What this trial is testing

The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being

Who this might be right for
Cervical Cancer
National Taiwan University Hospital 300
Not applicableUnknownNCT04633330
What this trial is testing

Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female

Who this might be right for
High Risk Human Papillomavirus InfectionLow Grade Squamous Intraepithelial Lesion
Shandong University 60
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Post-approval studies (Phase 4)Study completedNCT03943875
What this trial is testing

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Who this might be right for
ImmunizationEfficacyHuman Papilloma Virus
The University of Texas Medical Branch, Galveston 767
Testing effectiveness (Phase 2)Study completedNCT00693966
What this trial is testing

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 210
Testing effectiveness (Phase 2)Looking for participantsNCT06756269
What this trial is testing

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Who this might be right for
HPV InfectionHPV-Related CarcinomaHPV-Related Intraepithelial Neoplasia+1 more
Shanghai Bovax Biotechnology Co., Ltd. 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06705322
What this trial is testing

Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.

Who this might be right for
Human Papillomavirus (HPV) InfectionCervical Cancer
Fudan University 79
Large-scale testing (Phase 3)WithdrawnNCT06513884
What this trial is testing

HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma Recurrent
Hookipa Biotech GmbH
Not applicableStudy completedNCT03000933
What this trial is testing

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

Who this might be right for
Human PapillomavirusHuman Papillomavirus Infection
The Alfred 200
Not applicableActive Not RecruitingNCT04574635
What this trial is testing

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Who this might be right for
Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more
Mayo Clinic 18
Large-scale testing (Phase 3)Study completedNCT00543543
What this trial is testing

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 14,840
Testing effectiveness (Phase 2)WithdrawnNCT00365443
What this trial is testing

Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

Who this might be right for
Cervical CancerCondylomata Acuminata
Merck Sharp & Dohme LLC
Next Page